Sandy Cove Advisors’s NanoViricides NNVC Stock Holding History

Sandy Cove Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.8K	Hold	10,000	–	–	﹤0.01%	162
2026 Q1	$9.12K	Buy	+10,000	New	+$10.5K	﹤0.01%	144

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Sandy Cove Advisors's NNVC Position: Q2 2026 in Review

Sandy Cove Advisors held its NanoViricides (NNVC) position steady in Q2 2026 at 10,000 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #162.

Sandy Cove Advisors first reported a position in NNVC in Q1 2026 and has held it in 2 quarters since. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Sandy Cove Advisors held 10,000 shares of NanoViricides worth $13.8K as of Q2 2026.
Sandy Cove Advisors left its NanoViricides share count unchanged in Q2 2026.
NanoViricides made up ﹤0.01% of Sandy Cove Advisors's portfolio in Q2 2026, its #162 holding.
Sandy Cove Advisors first reported a position in NanoViricides in Q1 2026 and has held it in 2 quarters since.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Sandy Cove Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.